Alex Fair, CEO of MedStartr, has posted this Editor on their latest Crowd Challenge, this time at the AMIA Annual Symposium in San Francisco, 3-7 November. There are over 40 companies competing for five presentation spots in the AMIA 2018 PitchIT Competition on 5 November. What’s at stake? AMIA’s Informatics Partnership Council (IPC) sponsoring PitchIt has a prize of up $12,500, plus MedStartr has $25,000 in grants and entry into the MedStartr Acceleration Program. The link to the eligible companies is here on MedStartr, the leading crowdfunding platform exclusively for healthcare. Review, vote, and fund!
[grow_thumb image=”http://telecareaware.com/wp-content/uploads/2017/09/medstartr-400×400.jpg” thumb_width=”125″ /]Momentum 2017, PricewaterhouseCoopers headquarters, 300 Madison Avenue (42nd Street), NYC, 30 Nov (8.45am-5pm)-1 Dec (9am-3pm)
MedStartr/Health 2.0 NYC Momentum is back for a third year, returning to PwC’s NYC headquarters. The format is unusual because it blends nine speakers in Momentum Talks with five pitch contests and seven panels totaling over 70 participants on stage. The subject is all about driving innovation in healthcare from the wide variety of perspectives seen by patients, doctors, partners, institutions, and investors. Speakers, sponsors and agenda are all on the main page here.
The culmination is the award of the 2017 Grand National Challenge. Up to 25 teams will be invited to New York or the Healthcare Financial Summit 6-7 October in Las Vegas. Each winning team that enters the MedStartr Acceleration Program (MAP) will receive up to $250,000 in funding and services–and, as in all MedStartr Crowd Challenges, companies keep control of their pilots, partnerships, funds raised, investors engaged, and traction.
Registration is open–and early bird tickets are only $99. (You can’t get a better value!) More to come as we get closer to the event! TTA is a MedStartr and Health 2.0 NYC supporter/media sponsor since 2010; Editor Donna will be a host for this event and a MedStartr Mentor. Check the MedStartr page to find and fund some of the most interesting startup ideas in healthcare.
- Successful companies fit into a bigger picture. Startups into early-stage companies, which were the focus at #MedMo16, are now playing the niches like genetics, patient-focused discovery, condition management and cost-effective specialized clinical innovations.
- Anything that simplifies a process and saves money is attractive. Complex ‘big data’, analytics and ‘population health/integration’ solutions aren’t in the lead anymore because there are a lot of them and they all look alike.
- Nothing is revolutionary. The idea that an app, device or software will ‘revolutionize healthcare as we know it’ is now recognized as absurd. (The cocktail/drinks party is ovah!) Cases must be proved first, usually on your self-funded or FFF (families, friends and fools) dime, if you want to partner with the Big Dogs.
- Value-based care, this year’s darling, is already being seen as a vague ‘catch-all’ in a way that Triple Aim and ‘outcomes/evidence-based care’ were eventually found to be. As a meme, it’s turning out to have the life of a fruit fly.
- It has to be easy to access, preferably on something the average patient or clinician already has or can acquire easily, like a laptop, tablet or smartphone. The idea of having to place a special purpose-built device in, let’s say, a home, is looking more and more ‘analogue’ indeed, a trend we are seeing in the traditional hub-based telehealth market and even slowly in telecare and traditional PERS.
- Funding models are changing, with more bootstrapping, self-funding, expand you go and less emphasis on big investment and selling out fast. As funders on a NYeC DHC panel pointed out last Wednesday, don’t raise more – or less – than you need.
At #MedMo16, Crowd Challenge participants were judged by a combination of the interested MedStartr/Health 2.0 NYC community through the MedStartr funding platform, and then by a panel of judges who have leading clinical, technological, patient advocate and funding experience. In short, a group that has seen a lot over the past decade plus, has been up and down the Hype Cycle, and is down to Brass Tacks.
The innovations that bubbled up through the finalists (more…)